Aridis Pharmaceuticals, Inc. Share Price
Equities
ARDS
US0403341045
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.065 USD | 0.00% | +8.33% | -7.28% |
Sales 2023 * | 21.4M 1.78B | Sales 2024 * | 7.6M 634M | Capitalization | 3.12M 260M |
---|---|---|---|---|---|
Net income 2023 * | 4M 334M | Net income 2024 * | -4M -334M | EV / Sales 2023 * | 0.15 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 0.41 x |
P/E ratio 2023 * |
0.93
x | P/E ratio 2024 * |
-0.72
x | Employees | 37 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 85.16% |
1 week | +8.33% | ||
Current month | -16.67% | ||
1 month | -12.28% | ||
3 months | -13.91% | ||
6 months | -19.75% | ||
Current year | -7.28% |
Managers | Title | Age | Since |
---|---|---|---|
Vu Truong
CEO | Chief Executive Officer | 60 | 01/03/01 |
Eric Patzer
FOU | Founder | 75 | 01/03/01 |
Tamara Allen
DFI | Director of Finance/CFO | 57 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
John Hamilton
BRD | Director/Board Member | 79 | 01/15/01 |
Eric Patzer
FOU | Founder | 75 | 01/03/01 |
Vu Truong
CEO | Chief Executive Officer | 60 | 01/03/01 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.065 | 0.00% | 24,355 |
25/24/25 | 0.065 | +3.17% | 7,762 |
24/24/24 | 0.063 | -0.79% | 29,800 |
23/24/23 | 0.0635 | -1.55% | 148,984 |
22/24/22 | 0.0645 | +7.50% | 41,399 |
Delayed Quote OTC Markets, April 26, 2024 at 11:37 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.28% | 3.12M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ARDS Stock